Integer Initiates Strategic Review After Cutting Outlook

Dow Jones

Apr 30

By Katherine Hamilton

Integer has initiated a strategic review to consider a possible sale or merger.

The medical-device company initiated the review because it has received "strong interest," board chair Pamela Bailey said Thursday.

There is no deadline for the review and no assurance it will result in a transaction.

Integer separately lowered its outlook for 2026, citing headwinds with three of its products. Management has previously said that those products are not seeing the rate of adoption from customers that executives had expected.

The company now expects sales to be $1.81 billion to $1.84 billion, down from a prior range of $1.83 billion to $1.88 billion. It anticipates adjusted earnings per share will be $5.83 to $6.40, down from its earlier projection of $6.29 to $6.78.

Integer reported $439.6 million in revenue in the first quarter, which was roughly flat with the prior-year quarter.

The company swung to a profit of $16.5 million, or 48 cents a share, from a loss of $22.5 million, or 66 cents a share.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

April 30, 2026 08:48 ET (12:48 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/2631372036"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2631372036\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2631372036?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-30 20:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2631372036","market":"us","top_or_hot":-1,"title":"Integer Initiates Strategic Review After Cutting Outlook","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine Hamilton \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Integer has initiated a strategic review to consider a possible sale or merger. \n</p>\n<p>\n  The medical-device company initiated the review because it has received \"strong interest,\" board chair Pamela Bailey said Thursday. \n</p>\n<p>\n  There is no deadline for the review and no assurance it will result in a transaction. \n</p>\n<p>\n  Integer separately lowered its outlook for 2026, citing headwinds with three of its products. Management has previously said that those products are not seeing the rate of adoption from customers that executives had expected. \n</p>\n<p>\n  The company now expects sales to be $1.81 billion to $1.84 billion, down from a prior range of $1.83 billion to $1.88 billion. It anticipates adjusted earnings per share will be $5.83 to $6.40, down from its earlier projection of $6.29 to $6.78. \n</p>\n<p>\n  Integer reported $439.6 million in revenue in the first quarter, which was roughly flat with the prior-year quarter. \n</p>\n<p>\n  The company swung to a profit of $16.5 million, or 48 cents a share, from a loss of $22.5 million, or 66 cents a share. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 30, 2026 08:48 ET (12:48 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Integer Initiates Strategic Review After Cutting Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInteger Initiates Strategic Review After Cutting Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-04-30 20:48</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine Hamilton \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Integer has initiated a strategic review to consider a possible sale or merger. \n</p>\n<p>\n  The medical-device company initiated the review because it has received \"strong interest,\" board chair Pamela Bailey said Thursday. \n</p>\n<p>\n  There is no deadline for the review and no assurance it will result in a transaction. \n</p>\n<p>\n  Integer separately lowered its outlook for 2026, citing headwinds with three of its products. Management has previously said that those products are not seeing the rate of adoption from customers that executives had expected. \n</p>\n<p>\n  The company now expects sales to be $1.81 billion to $1.84 billion, down from a prior range of $1.83 billion to $1.88 billion. It anticipates adjusted earnings per share will be $5.83 to $6.40, down from its earlier projection of $6.29 to $6.78. \n</p>\n<p>\n  Integer reported $439.6 million in revenue in the first quarter, which was roughly flat with the prior-year quarter. \n</p>\n<p>\n  The company swung to a profit of $16.5 million, or 48 cents a share, from a loss of $22.5 million, or 66 cents a share. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 30, 2026 08:48 ET (12:48 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2631372036","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2631372036","pubTimestamp":1777553280,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Integer has initiated a strategic review to consider a possible sale or merger.The medical-device company initiated the review because it has received \"strong interest,\" board chair Pamela Bailey said Thursday.There is no deadline for the review and no assurance it will result in a transaction.Integer separately lowered its outlook for 2026, citing headwinds with three of its products. Management has previously said that those products are not seeing the rate of adoption from customers that executives had expected.The company now expects sales to be $1.81 billion to $1.84 billion, down from a prior range of $1.83 billion to $1.88 billion. It anticipates adjusted earnings per share will be $5.83 to $6.40, down from its earlier projection of $6.29 to $6.78.Integer reported $439.6 million in revenue in the first quarter, which was roughly flat with the prior-year quarter.The company swung to a profit of $16.5 million, or 48 cents a share, from a loss of $22.5 million, or 66 cents a share.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","LU1559883803.SGD":"Aberdeen Standard SICAV I - North American Smaller Companies Fund A Acc SGD-H","ITGR":"Integer Holdings Corporation","LU1815336091.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AUP\" (USD) INC","LU0757428866.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AE\" (USD) ACC","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","LU0566484027.USD":"安本美国小盘成长股","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC"},"translate_title":"Integer在下调前景后启动战略审查","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ITGR":1.5},"content_text":"By Katherine Hamilton \n\n\n \n\n\n  Integer has initiated a strategic review to consider a possible sale or merger. \n\n\n  The medical-device company initiated the review because it has received \"strong interest,\" board chair Pamela Bailey said Thursday. \n\n\n  There is no deadline for the review and no assurance it will result in a transaction. \n\n\n  Integer separately lowered its outlook for 2026, citing headwinds with three of its products. Management has previously said that those products are not seeing the rate of adoption from customers that executives had expected. \n\n\n  The company now expects sales to be $1.81 billion to $1.84 billion, down from a prior range of $1.83 billion to $1.88 billion. It anticipates adjusted earnings per share will be $5.83 to $6.40, down from its earlier projection of $6.29 to $6.78. \n\n\n  Integer reported $439.6 million in revenue in the first quarter, which was roughly flat with the prior-year quarter. \n\n\n  The company swung to a profit of $16.5 million, or 48 cents a share, from a loss of $22.5 million, or 66 cents a share. \n\n\n \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 30, 2026 08:48 ET (12:48 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}